CDKN2C and leukemia: Studies on the anticancer mechanism of peptide p18 in human leukemia K562 cells revealed that p18 causes the death of most K562 cells by depolarizing plasma membrane potential and enhancing membrane permeability, rather than activating the classical apoptosis pathway (23).